期刊
SAUDI PHARMACEUTICAL JOURNAL
卷 30, 期 7, 页码 979-1002出版社
ELSEVIER
DOI: 10.1016/j.jsps.2022.05.003
关键词
COVID-19; Coronavirus; Molecular dynamic simulation; Molecular docking; ADMET; Natural compounds; 3CLpro; SARS-CoV-2
资金
- Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, Saudi Arabia [GCV19-46-1441]
This study identified a potential SARS-CoV-2 inhibitor through virtual screening of a database of 78 natural antiviral compounds. Molecular docking and molecular dynamics simulations were used to analyze the interaction between the inhibitor and the key protease of SARS-CoV-2, revealing its ability to block viral replication and transcription. These findings are significant for the development of new drugs against SARS-CoV-2.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a more severe strain of coronavirus (CoV) that was first emerged in China in 2019. Available antiviral drugs could be repurposed and natural compounds with antiviral activity could be safer and cheaper source of medicine for SARS-CoV-2. 78 nat-ural antiviral compounds database was identified from literature and virtual screening technique was applied to identify potential 3-chymotrypsin-like protease (3CLpro) inhibitors. Molecular docking studies were conducted to analyze the main protease (3CLpro) and inhibitors interactions with key residues of active site of target protein (PDB ID: 6LU7), active site constitute the part of active domain I and II of 3CLpro. 10 compounds with highest dock score were subjected to calculate ADMET parameters to figure out drug-likeness. Molecular dynamic (MD) simulation of the selected lead was performed by Amber simulation package to understand the conformational changes in docked complex. MD simulations anal-ysis (RMSD, RMSF, Rg, BF, HBs, and SASA plots) of lead bounded with 3CLpro, hence revealed the impor-tant structural turns and twists during MD simulations from 0 to 100 ns. MM-PBSA/GBSA methods has also been applied for the estimation binding free energy (BFE) of the selected lead-complex. The present study has identified lead compound Forsythoside A an active extract of Forsythia suspense as SARS-CoV-2 3CLpro inhibitor that can block the viral replication and translation. Structural analysis of target protein and lead compound performed in this study could contribute to the development of potential drug against SARS-CoV-2 infection.(c) 2022 Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据